PARKINSONS-DISEASE AND DEMENTIA - CLINICAL AND NEUROCHEMICAL CORRELATIONS

被引:15
|
作者
STRITTMATTER, MM [1 ]
CRAMER, H [1 ]
机构
[1] UNIV FREIBURG, DEPT NEUROL & CLIN NEUROPHYSIOL, W-7800 FREIBURG, GERMANY
关键词
PARKINSONS DISEASE; ALZHEIMERS DISEASE; SUBGROUPS; SOMATOSTATIN; HVA; HIAA; CEREBROSPINAL FLUID;
D O I
10.1097/00001756-199205000-00009
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
IN 38 old aged parkinsonian patients, two major subgroups could be established: one with predominant akinesia, rigidity, postural instability and accompanying cognitive impairment with intellectual deterioration correlated with duration of disease but not with age of onset and another with predominant tremor and relatively intact intellectual functions. The mean somatostatin-like immunoreactivity (SLI) level in the cerebrospinal fluid (CSF) was significantly lower in parkinsonian patients (21.4+/-8.1 fmol ml-1) compared to senile control patients (29.5+/-9.4 fmol ml-1). In contrast to senile dementia of Alzheimer's type SLI was not correlated with dementia scores but with motor disease progression. Homovanillic acid (HVA) significantly decreased only in patients without L-DOPA treatment. Correlations between SLI, HVA and 5-hydroxyindole acetic acid (5-HIAA) indicate a degeneration of multiple neuronal networks which includes somatostatinergic neurons.
引用
收藏
页码:413 / 416
页数:4
相关论文
共 50 条
  • [1] NEUROCHEMICAL BASIS OF DEMENTIA IN PARKINSONS-DISEASE
    HORNYKIEWICZ, O
    KISH, SJ
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1984, 11 (01) : 185 - 190
  • [2] DEMENTIA AND PARKINSONS-DISEASE - PATHOLOGICAL AND NEUROCHEMICAL CONSIDERATIONS
    QUINN, NP
    ROSSOR, MN
    MARSDEN, CD
    BRITISH MEDICAL BULLETIN, 1986, 42 (01) : 86 - 90
  • [3] DEMENTIA AND PARKINSONS-DISEASE - BIOCHEMICAL AND CLINICOPATHOLOGICAL CORRELATIONS
    DUBOIS, B
    HAUW, JJ
    RUBERG, M
    SERDARU, M
    JAVOYAGID, F
    AGID, Y
    REVUE NEUROLOGIQUE, 1985, 141 (03) : 184 - 193
  • [4] PARKINSONS-DISEASE - THE POSSIBLE RELATIONSHIP OF LATERALITY TO DEMENTIA AND NEUROCHEMICAL FINDINGS
    DIRENFELD, LK
    ALBERT, ML
    VOLICER, L
    LANGLAIS, PJ
    MARQUIS, J
    KAPLAN, E
    ARCHIVES OF NEUROLOGY, 1984, 41 (09) : 935 - 941
  • [5] NEUROCHEMICAL POSTMORTEM STUDIES IN DEMENTIA OF THE ALZHEIMERS TYPE AND PARKINSONS-DISEASE
    RIEDERER, P
    ZEITSCHRIFT FUR GERONTOLOGIE, 1991, 24 (04): : 213 - 214
  • [6] CLINICAL, NEUROCHEMICAL AND THERAPEUTIC ASPECTS OF DEPRESSION IN PARKINSONS-DISEASE
    MECO, G
    FABRIZIO, E
    GASPARINI, M
    GIUSTINI, P
    GIORNALE DI NEUROPSICOFARMACOLOGIA, 1994, 16 (03): : 65 - 74
  • [7] DEMENTIA IN PARKINSONS-DISEASE
    TRITES, RL
    GRIMES, D
    QUARRINGTON, A
    KAPOOR, A
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1982, 9 (02) : 273 - 273
  • [8] DEMENTIA IN PARKINSONS-DISEASE
    MORTIMER, JA
    GERONTOLOGIST, 1985, 25 : 117 - 117
  • [9] DEMENTIA IN PARKINSONS-DISEASE
    PORTIN, R
    KOIVUSALO, A
    LAIHINEN, A
    RINNE, UK
    ACTA NEUROLOGICA SCANDINAVICA, 1988, 77 : 91 - 91
  • [10] PARKINSONS-DISEASE AND DEMENTIA
    MCCARTHY, R
    GRESTY, M
    FINDLEY, LJ
    LANCET, 1985, 1 (8425): : 407 - 407